載入...
Type I interferon antagonists in clinical development for lupus
INTRODUCTION: Systemic lupus erythematosus (SLE) is a severe chronic and incurable autoimmune disease. Treatment includes glucocorticoids and small molecule immunosuppressants which typically result in partial responses, and hence there is a great need for new therapies. The type I interferon (IFN)...
Na minha lista:
| 發表在: | Expert Opin Investig Drugs |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7924012/ https://ncbi.nlm.nih.gov/pubmed/32700979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543784.2020.1797677 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|